Heart repair by reprogramming non-myocytes with cardiac transcription factors

The adult mammalian heart possesses little regenerative potential following injury. Fibrosis due to activation of cardiac fibroblasts impedes cardiac regeneration and contributes to loss of contractile function, pathological remodelling and susceptibility to arrhythmias. Cardiac fibroblasts account for a majority of cells in the heart and represent a potential cellular source for restoration of cardiac function following injury through phenotypic reprogramming to a myocardial cell fate. Here we show that four transcription factors, GATA4, HAND2, MEF2C and TBX5, can cooperatively reprogram adult mouse tail-tip and cardiac fibroblasts into beating cardiac-like myocytes in vitro. Forced expression of these factors in dividing non-cardiomyocytes in mice reprograms these cells into functional cardiac-like myocytes, improves cardiac function and reduces adverse ventricular remodelling following myocardial infarction. Our results suggest a strategy for cardiac repair through reprogramming fibroblasts resident in the heart with cardiogenic transcription factors or other molecules.

[1]  S. Baek,et al.  Efficient inducible Cre‐mediated recombination in Tcf21cell lineages in the heart and kidney , 2011, Genesis.

[2]  Karl-Ludwig Laugwitz,et al.  Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages , 2005, Nature.

[3]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[4]  Lidia Szczupak,et al.  Gap junctions , 2004, Molecular Neurobiology.

[5]  Y. Suh,et al.  Myocardial injury‐induced fibroblast proliferation facilitates retroviral‐mediated gene transfer to the rat heart in vivo , 2000, The journal of gene medicine.

[6]  M. Crackower,et al.  Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein , 2001, Circulation research.

[7]  E. A. Packham,et al.  Physical Interaction between TBX5 and MEF2C Is Required for Early Heart Development , 2009, Molecular and Cellular Biology.

[8]  K. Schechtman,et al.  Effects of diminished expression of connexin43 on gap junction number and size in ventricular myocardium. , 2000, American journal of physiology. Heart and circulatory physiology.

[9]  Douglas A. Melton,et al.  In vivo reprogramming of adult pancreatic exocrine cells to β-cells , 2008, Nature.

[10]  M. Zang,et al.  Cooperative Interaction between the Basic Helix-loop-helix Transcription Factor dHAND and Myocyte Enhancer Factor 2C Regulates Myocardial Gene Expression* , 2004, Journal of Biological Chemistry.

[11]  M. Grigorian,et al.  S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. , 2007, Cardiovascular research.

[12]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[13]  P. Menasché Cell-based therapy for heart disease: a clinically oriented perspective. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[15]  J. Hell,et al.  Physical and Functional Interaction Between Calcineurin and the Cardiac L-Type Ca2+ Channel , 2009, Circulation research.

[16]  E. Olson,et al.  Transient Regenerative Potential of the Neonatal Mouse Heart , 2011, Science.

[17]  S. Muallem,et al.  Aberrant Localization of Intracellular Organelles, Ca2+ Signaling, and Exocytosis in Mist1 Null Mice* , 2005, Journal of Biological Chemistry.

[18]  E. Olson,et al.  A Dynamic Notch Injury Response Activates Epicardium and Contributes to Fibrosis Repair , 2011, Circulation Research.

[19]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[20]  B. Jugdutt,et al.  Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? , 2003, Circulation.

[21]  J. Robbins,et al.  Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.

[22]  Dejian Lai,et al.  Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. , 2012, JAMA.

[23]  Maria Teresa Dell'Anno,et al.  Direct generation of functional dopaminergic neurons from mouse and human fibroblasts , 2011, Nature.

[24]  Richard T. Lee,et al.  Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. , 2011, Cell stem cell.

[25]  V. Vedantham,et al.  Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.

[26]  N. Chao Faculty Opinions recommendation of In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. , 2008 .

[27]  Jonathan C. Cohen,et al.  GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5 , 2003, Nature.

[28]  S. Tapscott,et al.  MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. , 1988, Science.

[29]  Jeffrey Robbins,et al.  Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury , 2007, Nature Medicine.

[30]  G. Brower,et al.  Regulation of matrix metalloproteinases is at the heart of myocardial remodeling. , 2008, American journal of physiology. Heart and circulatory physiology.

[31]  C. Blanpain,et al.  Mesp1: A Key Regulator of Cardiovascular Lineage Commitment , 2010, Circulation research.

[32]  N. Turner,et al.  Cardiac fibroblasts: at the heart of myocardial remodeling. , 2009, Pharmacology & therapeutics.

[33]  T. Ratliff TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .

[34]  B. Small,et al.  Validation of a voltage-sensitive dye (di-4-ANEPPS)-based method for assessing drug-induced delayed repolarisation in beagle dog left ventricular midmyocardial myocytes. , 2009, Journal of pharmacological and toxicological methods.

[35]  G. Nolan,et al.  Efficient screening of retroviral cDNA expression libraries. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Schneider A Key Regulator of Cardiovascular Lineage Commitment , 2010 .

[37]  Da-Zhi Wang,et al.  Myocardin is a master regulator of smooth muscle gene expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Molkentin,et al.  The Transcription Factors GATA4 and dHAND Physically Interact to Synergistically Activate Cardiac Gene Expression through a p300-dependent Mechanism* , 2002, The Journal of Biological Chemistry.

[39]  David J. Miller,et al.  Gene Regulatory Networks in the Evolution and Development of the Heart , 2006 .

[40]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[41]  N. Rosenthal,et al.  The future of regenerative therapy in patients with chronic heart failure , 2006, Nature Clinical Practice Cardiovascular Medicine.

[42]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[43]  J. Hoover-Plow,et al.  Challenges for heart disease stem cell therapy , 2012, Vascular health and risk management.

[44]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[45]  J. Hell,et al.  Physical and Functional Interaction Between Calcineurin and the Cardiac L-Type Ca 2 Channel , 2009 .